• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
Home/End-to-End Capabilities/Next-Generation Sequencing

Next-Generation Sequencing

// End-to-end
   Capabilities

Rapid Next-Generation Sequencing Services are Designed to Support all Cell and Gene Therapy Modalities

ElevateBio’s next-generation sequencing (NGS) leverages advanced technologies and expertise to provide flexibility, customizability, and rapid turnaround times.

Our team of experts is ready to collaborate on the design and optimization of assays and targets, offering tailored consultation services across all workflow stages. Our partners also benefit from seamless integration with cGMP manufacturing and process development capabilities at BaseCamp.

Adriana Geldart

Senior Director, Next-Generation Sequencing

We are Enabling Industry Partners with our NGS services

Instrumentation & Capabilities
Data Quality
Applications
Instrumentation & Capabilities

Instrumentation & Capabilities

We have an ever-expanding range of next-generation sequencing capabilities with integrated bioinformatics analysis and robust instrumentation including Illumina, Oxford Nanopore, and 10x Genomics.

Data Quality

Data Quality

Our end-to-end processes—from sample recording to preparation and data analysis—are powered by digital-native automated pipelines and laboratory automation, designed for scalability and high-throughput efficiency. We achieve requisite coverage without compromising accuracy or quality through optimized protocols, assay controls, and automated bioinformatics. This integration leads to faster turnaround, with workflows reduced to <1 week and data for advanced assays delivered 2-4 weeks faster than industry standard.

Applications

Applications

We offer a range of sequencing solutions, including amplicon, whole exome, whole genome, RNA (including single-cell), methyl, and complete plasmid.

Download our NGS Fact Sheet

Our Therapeutic Approaches

We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.

Learn about our therapeutic designs

Our Technology Platforms

Our next-generation enabling technologies and platforms offer the potential to pursue a broad range of therapeutic designs and applications. With proprietary gene editing, cell therapy, and RNA, protein, and vector technologies and the ability to combine them, we can power the entire cell and gene therapy industry.

Learn about our technology

Partner with ElevateBio®

Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.

Work with Us

// Work with us

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact
MENU
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact